In the U.S., Elucirem is indicated in adults and now in pediatric patients including term neonates, for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal ...
Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years — — Conference call today at 4:30 p.m. ET — BRISBANE, Calif., Feb. 26, 2026 ...
The FDA has relaxed a clinical hold on clinical trials of Novartis' intrathecal formulation of spinal muscular atrophy (SMA) gene therapy Zolgensma, allowing a new phase 3 trial to get underway.
The "Electronic Drug Delivery System Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's ...
Terra Planet Earth on MSN
Why Earth’s deadliest venomous creature is neither a snake nor a scorpion
Behind a pretty shell sits a precision hunter whose toxins can stop a heartbeat, yet also power pain relief and new diabetes ...
Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results